What GLP-1s do in your body: Stimulate insulin release from pancreatic beta cells Slow gastric emptying, which reduces appetite Get metabolized primarily by the liver Are cleared partially through kidney function Have unknown long-term effects on thyroid C-cells Nearly half of patients stop GLP-1 therapy within the first year
Managing this condition requires lifelong B12 supplementation (usually via injection) and regular veterinary monitoring
Peptide therapy may be discussed for recovery support, energy, mobility, healthy aging, body composition, skin wellness, and active lifestyle goals
Should GHK-Cu be injected subcutaneously or intramuscularly
Whilst caloric restriction is therapeutically appropriate, inadequate attention to dietary quality and micronutrient density can result in nutritional deficiencies , including B12, folate, iron, and other essential nutrients
In an unadjusted Cox regression model, individuals with the AG genotype and those with the AA genotype were at significantly increased risk of vitamin B 12 deficiency compared with those in the GG genotype reference group (additive model